Blackhawk Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,987
Closed -$1.44M 70
2020
Q1
$1.44M Sell
5,987
-275
-4% -$60.1K 1.29% 29
2019
Q4
$1.21M Buy
6,262
+34
+0.5% +$7.5K 1.21% 32
2019
Q3
$1.21M Sell
6,228
-8
-0.1% -$1.54K 1.13% 34
2019
Q2
$1.15M Buy
6,236
+726
+13% +$130K 1.1% 34
2019
Q1
$1.05M Buy
5,510
+452
+9% +$86.3K 1.08% 36
2018
Q4
$985K Sell
5,058
-184
-4% -$35.9K 1.26% 35
2018
Q3
$1.09M Sell
5,242
-159
-3% -$31.3K 1.54% 26
2018
Q2
$997K Sell
5,401
-560
-9% -$99.1K 1.13% 30
2018
Q1
$1.02M Sell
5,961
-208
-3% -$38.2K 0.86% 37
2017
Q4
$1.07M Buy
+6,169
New +$1.09M 0.93% 32

Other funds holding AMGN

Blackhawk Capital Partners's AMGN Position: Q2 2020 in Review

Blackhawk Capital Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 5,987 shares — an estimated $1.44M sold.

Blackhawk Capital Partners first reported a position in AMGN in Q4 2017 and held it in 10 quarters. The position peaked at $1.44M in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Blackhawk Capital Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • Blackhawk Capital Partners sold 5,987 Amgen shares in Q2 2020, an estimated $1.44M.
  • Blackhawk Capital Partners first reported a position in Amgen in Q4 2017 and held it in 10 quarters.
  • Blackhawk Capital Partners's Amgen position peaked at $1.44M in Q1 2020.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Blackhawk Capital Partners's 13F filing for Q2 2020, filed 4 Aug 2020.